All News about Bristol-Myers Squibb
![](https://cdn.benzinga.com/files/images/story/2024/JoeBiden-Michigan-Shutterstock_0.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240306806082/en/2041631/5/bms_logo_300_rgb_pos.jpg)
From Bristol Myers Squibb
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2023/07/wealth-management1600-.png)
![](https://cdn.benzinga.com/files/images/story/2024/joe-biden-shutter4_9.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Bristol-Myers Squibb's Options Frenzy: What You Need to Know
March 04, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
A Closer Look at Bristol-Myers Squibb's Options Market Dynamics
February 22, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
How Is The Market Feeling About Bristol-Myers Squibb?
February 21, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/options_image_0.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks Whale Activity In Today's Session
March 04, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240301262898/en/2041631/5/bms_logo_300_rgb_pos.jpg)
![](https://investorplace.com/wp-content/uploads/2023/05/ai-stocks1600-5.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2024/Ardelyx-ARDX_3.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240226516046/en/2041631/5/bms_logo_300_rgb_pos.jpg)
![](https://mms.businesswire.com/media/20240224641228/en/839392/22/BMY_Logo.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://mms.businesswire.com/media/20240221131768/en/2041631/5/bms_logo_300_rgb_pos.jpg)
![](https://mms.businesswire.com/media/20240222161139/en/839392/22/BMY_Logo.jpg)
Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer
February 23, 2024
From Bristol Myers Squibb
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2022/01/brain-1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2024/01/oversold-stocks-to-buy.jpg)
![](https://g.foolcdn.com/editorial/images/765797/a-couple-smiling-and-talking-with-an-advisor.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/cannabis-deals-geralt--lindsayfox-Pixaba_3.jpeg?width=1200&height=800&fit=crop)
Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes
February 20, 2024
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
![](https://mms.businesswire.com/media/20240219104533/en/785876/5/BMS_LOGO.jpg)
From Bristol Myers Squibb
Via Business Wire
![](https://g.foolcdn.com/editorial/images/765146/doctor-holding-elderly-patients-hand.jpg)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://mms.businesswire.com/media/20240214420778/en/785876/5/BMS_LOGO.jpg)
Bristol Myers Squibb Prices $13 Billion of Senior Unsecured Notes
February 14, 2024
From Bristol Myers Squibb
Via Business Wire
![](https://mms.businesswire.com/media/20240214620395/en/785876/5/BMS_LOGO.jpg)
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
![](https://mms.businesswire.com/media/20240213315041/en/785876/5/BMS_LOGO.jpg)
![](https://ml.globenewswire.com/media/9c3ffae4-603d-404f-93cf-1106337e9e0b/small/finacialnews-logo-final-01-2-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.